Encyclopedia

  • Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters
  • Add time:07/21/2019         Source:sciencedirect.com

    Photodynamic therapy (PDT) is a tool for the treatment of certain cancerous and pre-cancerous conditions in dermatology. 5-Aminolevulinic acid (5-ALA) and simple derivatives thereof are the principal compounds used for this purpose. For optimal efficacy, the drug must be released at an appropriate rate from the formulation and penetrate the skin, ideally to reach the target tissue at a sufficiently high concentration. Because ALA is a polar, zwitterionic compound, its formulation in conventional topical vehicles, and its inherently poor skin permeability, poses important challenges for the pharmaceutical scientist. The synthesis of more lipophilic (e.g. ester) prodrugs of ALA resolves, in part, these issues but then demands that questions, related to biotransformation back to the parent 5-ALA and to stability, be addressed. The objective of this review, therefore, is to evaluate the state-of-the-art and identify those areas in which additional research is necessary.

    We also recommend Trading Suppliers and Manufacturers of CARBOBENZYLOXY-L-PHENYLALANYL-L-VALINE METHYL ESTER (cas 15027-26-6). Pls Click Website Link as below: cas 15027-26-6 suppliers


    Prev:Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second “touch point”
    Next: Enzymatic resolution of (±)-cis- and (±)-trans-1-aminoindan-2-ol and (±)-cis- and (±)-trans-2-aminoindan-1-ol (cas 15028-16-7))

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View